首页> 外文会议>SPIE Medical Imaging Conference >Improving Classification with Forced Labeling of Other Related Classes: Application to Prediction of Upstaged Ductal Carcinoma in situ Using Mammographic Features
【24h】

Improving Classification with Forced Labeling of Other Related Classes: Application to Prediction of Upstaged Ductal Carcinoma in situ Using Mammographic Features

机译:用其他相关类别的强制标记改善分类:在使用乳腺X线摄影特征预测上位性导管癌的应用

获取原文

摘要

Predicting whether ductal carcinoma in situ (DCIS) identified at core biopsy contains occult invasive disease is an import task since these "upstaged" cases will affect further treatment planning. Therefore, a prediction model that better classifies pure DCIS and upstaged DCIS can help avoid overtreatment and overdiagnosis. In this work, we propose to improve this classification performance with the aid of two other related classes: Atypical Ductal Hyperplasia (ADH) and Invasive Ductal Carcinoma (IDC). Our data set contains mammograms for 230 cases. Specifically. 66 of them are ADH cases; 99 of them are biopsy-proven DCIS cases, of whom 25 were found to contain invasive disease at the time of definitive surgery. The remaining 65 cases were diagnosed with IDC at core biopsy. Our hypothesis is that knowledge can be transferred from training with the easier and more readily available cases of benign but suspicious ADH versus IDC that is already apparent at initial biopsy. Thus, embedding both ADH and IDC cases to the classifier will improve the performance of distinguishing upstaged DCIS from pure DCIS. We extracted 113 mammographic features based on a radiologist's annotation of clusters.Our method then added both ADH and IDC cases during training, where ADH were "force labeled" or treated by the classifier as pure DCIS (negative) cases, and IDC were labeled as upstaged DCIS (positive) cases. A logistic regression classifier was built based on the designed training dataset to perform a prediction of whether biopsy-proven DCIS cases contain invasive cancer. The performance was assessed by repeated 5-fold Cross-Validation and Receiver Operating Characteristic(ROC) curve analysis. While prediction performance with only training on DCIS dataset had an average AUC of 0.607(%95CI, 0.479-0.721). By adding both ADH and IDC cases for training, we improved the performance to 0.691(95%CI. 0.581-0.801).
机译:预测在核心活检中确定的导管原位癌(DCIS)是否包含隐匿性浸润性疾病是一项重要的任务,因为这些“升级的”病例将影响进一步的治疗计划。因此,更好地将纯DCIS和升级的DCIS进行分类的预测模型可以帮助避免过度治疗和过度诊断。在这项工作中,我们建议借助其他两个相关类别来提高分类性能:非典型性导管增生(ADH)和侵袭性导管癌(IDC)。我们的数据集包含230例乳房X线照片。具体来说。其中66例属于ADH案件;其中99例是经活检证实的DCIS病例,其中25例在确定性手术时被发现含有浸润性疾病。其余65例在核心活检中被诊断为IDC。我们的假设是,可以通过更容易,更容易获得的良性但可疑ADH与IDC的案例从培训中转移知识,这些案例在初次活检时就已经很明显了。因此,将ADH和IDC案例都嵌入分类器将提高区分升级后的DCIS和纯DCIS的性能。我们根据放射学家对簇的注释提取了113个乳房X线照片特征。然后,在训练过程中,我们同时添加了ADH和IDC病例,其中ADH被“强制标记”或被分类器视为纯DCIS(阴性)病例,IDC被标记为升级的DCIS(阳性)病例。基于设计的训练数据集构建了逻辑回归分类器,以进行活检证实的DCIS病例是否包含浸润性癌症的预测。通过重复的5倍交叉验证和接收器工作特征(ROC)曲线分析来评估性能。而仅在DCIS数据集上进行训练的预测性能的平均AUC为0.607(%95CI,0.479-0.721)。通过同时添加ADH和IDC案例进行培训,我们将性能提高到0.691(95%CI。0.581-0.801)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号